Skip to main content
Top
Published in: BMC Nephrology 1/2015

Open Access 01-12-2015 | Research article

How has peritoneal dialysis changed over the last 30 years: experience of the Verona dialysis center

Authors: Gianluigi Zaza, Carlo Rugiu, Alessandra Trubian, Simona Granata, Albino Poli, Antonio Lupo

Published in: BMC Nephrology | Issue 1/2015

Login to get access

Abstract

Background

The last decade has witnessed considerable improvement in dialysis technology and changes in clinical management of patients in peritoneal dialysis (PD) with a significant impact on long term clinical outcomes. However, the identification of factors involved in this process is still not complete.

Methods

Therefore, to assess this objective, we retrospectively analyzed clinical records of 260 adult patients who started PD treatment from 1983 to 2012 in our renal unit. For the analysis, we divided them into three groups according to the time of starting dialysis: GROUP A (n: 62, 1983–1992), GROUP B (n: 66, 1993–2002) and GROUP C (n: 132, 2003 to 2012).

Results

Statistical analysis revealed that patients included in the GROUP C showed a reduction in mean patients’ age (p = 0.03), smoking habit (p = 0.001), mean systolic blood pressure (p < 0.0001) and an increment in hemoglobin levels (p < 0.0001) and residual diuresis (p = 0.016) compared to the other two study groups. Additionally, patients included in GROUP C, mainly treated with automated peritoneal dialysis, showed a reduced risk of all-causes mortality and a decreased risk to develop acute myocardial infarction and cerebrovascular disease. Patients’ age, diabetes mellitus and smoking habit were all positively associated with a significant increased risk of mortality in our PD patients, while serum albumin levels and residual diuresis were negatively correlated.

Conclusions

Therefore, the present study, revealed that in the last decade there has been a growth of our PD program with a concomitant modification of our patients’ characteristics. These changes, together with the evident technical advances, have caused a significant improvement of patients’ survival and a decrement of the rate of hospitalization. Moreover, it reveals that our pre-dialysis care, modifying the above-mentioned factors, has been a major cause of these clinical improvements.
Appendix
Available only for authorised users
Literature
1.
go back to reference National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;392 Suppl 1:S1–266. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;392 Suppl 1:S1–266.
2.
go back to reference Biesenbach G, Pohanka E. Dialysis in diabetic patients: hemodialysis and peritoneal dialysis. Pros Cons Minerva Uro lNefrol. 2012;64(3):173–82. Biesenbach G, Pohanka E. Dialysis in diabetic patients: hemodialysis and peritoneal dialysis. Pros Cons Minerva Uro lNefrol. 2012;64(3):173–82.
4.
go back to reference Marinangeli G, Cabiddu G, Neri L, Viglino G, Russo R, Teatini U, et al. Old and new perspectives on peritoneal dialysis in italy emerging from the peritoneal dialysis study group census. Perit Dial Int. 2012;32(5):558–65.CrossRefPubMedPubMedCentral Marinangeli G, Cabiddu G, Neri L, Viglino G, Russo R, Teatini U, et al. Old and new perspectives on peritoneal dialysis in italy emerging from the peritoneal dialysis study group census. Perit Dial Int. 2012;32(5):558–65.CrossRefPubMedPubMedCentral
5.
go back to reference Van Biesen W, Verbeke F, Vanholder R. Cardiovascular disease in haemodialysis and peritoneal dialysis: arguments pro peritoneal dialysis. Nephrol Dial Transplant. 2007;22(1):53–8.CrossRefPubMed Van Biesen W, Verbeke F, Vanholder R. Cardiovascular disease in haemodialysis and peritoneal dialysis: arguments pro peritoneal dialysis. Nephrol Dial Transplant. 2007;22(1):53–8.CrossRefPubMed
6.
go back to reference Tam P. Peritoneal dialysis and preservation of residual renal function. Perit Dial Int. 2009;29 Suppl 2:S108–10.PubMed Tam P. Peritoneal dialysis and preservation of residual renal function. Perit Dial Int. 2009;29 Suppl 2:S108–10.PubMed
7.
go back to reference Theofilou P. Quality of life in patients undergoing hemodialysis or peritoneal dialysis treatment. J Clin Med Res. 2011;3(3):132–8.PubMedPubMedCentral Theofilou P. Quality of life in patients undergoing hemodialysis or peritoneal dialysis treatment. J Clin Med Res. 2011;3(3):132–8.PubMedPubMedCentral
9.
go back to reference Kalantar-Zadeh K, Kopple JD. Relative contribution of nutrition and inflammation to clinical outcome in dialysis patients. Am J Kidney Dis. 2001;38:1343–50.CrossRefPubMed Kalantar-Zadeh K, Kopple JD. Relative contribution of nutrition and inflammation to clinical outcome in dialysis patients. Am J Kidney Dis. 2001;38:1343–50.CrossRefPubMed
10.
go back to reference Noh H, Kim JS, Han KH, Lee GT, Song JS, Chung SH, et al. Oxidative stress duringperitoneal dialysis: implications in functional and structural changes in themembrane. Kidney Int. 2006;69:2022–8.CrossRefPubMed Noh H, Kim JS, Han KH, Lee GT, Song JS, Chung SH, et al. Oxidative stress duringperitoneal dialysis: implications in functional and structural changes in themembrane. Kidney Int. 2006;69:2022–8.CrossRefPubMed
11.
go back to reference Breborowicz A. Free radicals in peritoneal dialysis: agents of damage? Perit Dial Int. 1992;12:194–8.PubMed Breborowicz A. Free radicals in peritoneal dialysis: agents of damage? Perit Dial Int. 1992;12:194–8.PubMed
12.
go back to reference Wang AY. Cardiovascular risk factors in peritoneal dialysis patients revisited. Perit Dial Int. 2007;27 Suppl 2:S223–7.PubMed Wang AY. Cardiovascular risk factors in peritoneal dialysis patients revisited. Perit Dial Int. 2007;27 Suppl 2:S223–7.PubMed
13.
go back to reference Dong J, Han QF, Zhu TY, Ren YP, Chen JH, Zhao HP, et al. The associations of uric acid, cardiovascular and all-cause mortality in peritoneal dialysis patients. PLoS One. 2014;9(1):e82342.CrossRefPubMedPubMedCentral Dong J, Han QF, Zhu TY, Ren YP, Chen JH, Zhao HP, et al. The associations of uric acid, cardiovascular and all-cause mortality in peritoneal dialysis patients. PLoS One. 2014;9(1):e82342.CrossRefPubMedPubMedCentral
14.
go back to reference Stinghen AE, Barretti P, Pecoits-Filho R. Factors contributing to the differences in peritonitis rates between centers and regions. Perit Dial Int. 2007;27 Suppl 2:S281–5.PubMed Stinghen AE, Barretti P, Pecoits-Filho R. Factors contributing to the differences in peritonitis rates between centers and regions. Perit Dial Int. 2007;27 Suppl 2:S281–5.PubMed
15.
go back to reference Mehrotra R, Story K, Guest S. FedunyszynM. Neighborhood location, rurality, geography, and outcomes of peritoneal dialysis patients in the United States. Perit Dial Int. 2012;32(3):322–31.CrossRefPubMedPubMedCentral Mehrotra R, Story K, Guest S. FedunyszynM. Neighborhood location, rurality, geography, and outcomes of peritoneal dialysis patients in the United States. Perit Dial Int. 2012;32(3):322–31.CrossRefPubMedPubMedCentral
16.
go back to reference Tonelli M, Hemmelgarn B, Culleton B, Klarenbach S, Gill JS, Wiebe N, et al. Mortality of Canadians treated by peritoneal dialysis in remote locations. Kidney Int. 2007;72:1023–8.CrossRefPubMed Tonelli M, Hemmelgarn B, Culleton B, Klarenbach S, Gill JS, Wiebe N, et al. Mortality of Canadians treated by peritoneal dialysis in remote locations. Kidney Int. 2007;72:1023–8.CrossRefPubMed
17.
go back to reference Wang AY, Wang M, Lam CW, Chan IH, Lui SF, Sanderson JE. Heart failure in long-term peritoneal dialysis patients: a 4-year prospective analysis. Clin J Am Soc Nephrol. 2011;6(4):805–12.CrossRefPubMedPubMedCentral Wang AY, Wang M, Lam CW, Chan IH, Lui SF, Sanderson JE. Heart failure in long-term peritoneal dialysis patients: a 4-year prospective analysis. Clin J Am Soc Nephrol. 2011;6(4):805–12.CrossRefPubMedPubMedCentral
18.
go back to reference Lee HY, Park HC, Seo BJ, Lee HY, Park HC, Seo BJ, et al. Superior patient survival for continuous ambulatory peritoneal dialysis patients treated with a peritoneal dialysis fluid with neutral pH and low glucose degradation product concentration (balance). Perit Dial Int. 2005;25(3):248–55.PubMed Lee HY, Park HC, Seo BJ, Lee HY, Park HC, Seo BJ, et al. Superior patient survival for continuous ambulatory peritoneal dialysis patients treated with a peritoneal dialysis fluid with neutral pH and low glucose degradation product concentration (balance). Perit Dial Int. 2005;25(3):248–55.PubMed
19.
20.
go back to reference Khan SS, Xue JL, Kazmi WH, Gilbertson DT, Obrador GT, Pereira BJ, et al. Does predialysis nephrology care influence patient survival after initiation of dialysis? Kidney Int. 2005;67(3):1038–46.CrossRefPubMed Khan SS, Xue JL, Kazmi WH, Gilbertson DT, Obrador GT, Pereira BJ, et al. Does predialysis nephrology care influence patient survival after initiation of dialysis? Kidney Int. 2005;67(3):1038–46.CrossRefPubMed
21.
go back to reference Foote C, Ninomiya T, Gallagher M, Perkovic V, Cass A, McDonald SP, et al. Survival of elderly dialysis patients is predicted by both patient and practice characteristics. Nephrol Dial Transplant. 2012;27(9):3581–7.CrossRefPubMed Foote C, Ninomiya T, Gallagher M, Perkovic V, Cass A, McDonald SP, et al. Survival of elderly dialysis patients is predicted by both patient and practice characteristics. Nephrol Dial Transplant. 2012;27(9):3581–7.CrossRefPubMed
22.
go back to reference Verdalles U, Abad S, Aragoncillo I, Villaverde M, Jofre R, Verde E, et al. Factors predicting mortality in elderly patients on dialysis. Nephron ClinPract. 2010;115(1):c28–34.CrossRef Verdalles U, Abad S, Aragoncillo I, Villaverde M, Jofre R, Verde E, et al. Factors predicting mortality in elderly patients on dialysis. Nephron ClinPract. 2010;115(1):c28–34.CrossRef
23.
go back to reference Brown EA. Peritoneal dialysis in elderly patients: clinical experience. Perit Dial Int. 2005;25 Suppl 3:S88–91.PubMed Brown EA. Peritoneal dialysis in elderly patients: clinical experience. Perit Dial Int. 2005;25 Suppl 3:S88–91.PubMed
24.
go back to reference Lim WH, Dogra GK, McDonald SP, Brown FG, Johnson DW. Compared with younger peritoneal dialysis patients, elderly patients have similar peritonitis-free survival and lower risk of technique failure, but higher risk of peritonitis-related mortality. Perit Dial Int. 2011;31(6):663–71.CrossRefPubMed Lim WH, Dogra GK, McDonald SP, Brown FG, Johnson DW. Compared with younger peritoneal dialysis patients, elderly patients have similar peritonitis-free survival and lower risk of technique failure, but higher risk of peritonitis-related mortality. Perit Dial Int. 2011;31(6):663–71.CrossRefPubMed
25.
go back to reference Nessim SJ, Bargman JM, Austin PC, Story K, Jassal SV. Impact of age on peritonitis risk in peritoneal dialysis patients: an era effect. Clin J Am Soc Nephrol. 2009;4:135–41.CrossRefPubMedPubMedCentral Nessim SJ, Bargman JM, Austin PC, Story K, Jassal SV. Impact of age on peritonitis risk in peritoneal dialysis patients: an era effect. Clin J Am Soc Nephrol. 2009;4:135–41.CrossRefPubMedPubMedCentral
26.
go back to reference Okayama M, Inoue T, Nodaira Y, Kimura Y, Nobe K, Seto T, et al. Aging is an important risk factor for peritoneal dialysis-associated peritonitis. Adv Perit Dial. 2012;28:50–4.PubMed Okayama M, Inoue T, Nodaira Y, Kimura Y, Nobe K, Seto T, et al. Aging is an important risk factor for peritoneal dialysis-associated peritonitis. Adv Perit Dial. 2012;28:50–4.PubMed
27.
go back to reference Duong U, Mehrotra R, Molnar MZ, Noori N, Kovesdy CP, Nissenson AR, et al. Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus. Clin J Am Soc Nephrol. 2011;6(5):1041–8.CrossRefPubMedPubMedCentral Duong U, Mehrotra R, Molnar MZ, Noori N, Kovesdy CP, Nissenson AR, et al. Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus. Clin J Am Soc Nephrol. 2011;6(5):1041–8.CrossRefPubMedPubMedCentral
28.
go back to reference Paniagua R, Ventura MJ, Avila-Díaz M, Cisneros A, Vicenté-Martínez M, Furlong MC, et al. Icodextrin improves metabolic and fluid management in high and high-average transport diabetic patients. Perit Dial Int. 2009;29:422–32.PubMed Paniagua R, Ventura MJ, Avila-Díaz M, Cisneros A, Vicenté-Martínez M, Furlong MC, et al. Icodextrin improves metabolic and fluid management in high and high-average transport diabetic patients. Perit Dial Int. 2009;29:422–32.PubMed
29.
go back to reference Braatvedt GD, Rosie B, Bagg W, Collins J. Current and former smoking increases mortality in patients on peritoneal dialysis. N Z Med J. 2006;119(1234):U1977.PubMed Braatvedt GD, Rosie B, Bagg W, Collins J. Current and former smoking increases mortality in patients on peritoneal dialysis. N Z Med J. 2006;119(1234):U1977.PubMed
30.
go back to reference Diaz-Buxo JA, Lowrie EG, Lew NL, Zhang SM, Zhu X, Lazarus JM. Associates of mortality among peritoneal dialysis patients with special reference to peritoneal transport rates and solute clearance. Am J Kidney Dis. 1999;33(3):523–34.CrossRefPubMed Diaz-Buxo JA, Lowrie EG, Lew NL, Zhang SM, Zhu X, Lazarus JM. Associates of mortality among peritoneal dialysis patients with special reference to peritoneal transport rates and solute clearance. Am J Kidney Dis. 1999;33(3):523–34.CrossRefPubMed
31.
go back to reference Mehrotra R, Kopple JD. Protein and energy nutrition among adult patients treated with chronic peritoneal dialysis. Adv Ren Replace Ther. 2003;10(3):194–212.CrossRefPubMed Mehrotra R, Kopple JD. Protein and energy nutrition among adult patients treated with chronic peritoneal dialysis. Adv Ren Replace Ther. 2003;10(3):194–212.CrossRefPubMed
32.
go back to reference Wang Q, Bernardini J, Piraino B, Fried L. Albumin at the start of peritoneal dialysis predicts the development of peritonitis. Am J Kidney Dis. 2003;41(3):664–9.CrossRefPubMed Wang Q, Bernardini J, Piraino B, Fried L. Albumin at the start of peritoneal dialysis predicts the development of peritonitis. Am J Kidney Dis. 2003;41(3):664–9.CrossRefPubMed
33.
go back to reference Mehrotra R, Duong U, Jiwakanon S, Kovesdy CP, Moran J, Kopple JD, et al. Serum albumin as a predictor of mortality in peritoneal dialysis: comparisons with hemodialysis. Am J Kidney Dis. 2011;58(3):418–28.CrossRefPubMedPubMedCentral Mehrotra R, Duong U, Jiwakanon S, Kovesdy CP, Moran J, Kopple JD, et al. Serum albumin as a predictor of mortality in peritoneal dialysis: comparisons with hemodialysis. Am J Kidney Dis. 2011;58(3):418–28.CrossRefPubMedPubMedCentral
34.
go back to reference Westra WM, Kopple JD, Krediet RT, Appell M, Mehrotra R. Dietary protein requirements and dialysate protein losses in chronic peritoneal dialysis patients. Perit Dial Int. 2007;27(2):192–5.PubMed Westra WM, Kopple JD, Krediet RT, Appell M, Mehrotra R. Dietary protein requirements and dialysate protein losses in chronic peritoneal dialysis patients. Perit Dial Int. 2007;27(2):192–5.PubMed
35.
go back to reference de Mutsert R, Grootendorst DC, Indemans F, Boeschoten EW, Krediet RT, Dekker FW. Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition. J Ren Nutr. 2009;19(2):127–35.CrossRefPubMed de Mutsert R, Grootendorst DC, Indemans F, Boeschoten EW, Krediet RT, Dekker FW. Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition. J Ren Nutr. 2009;19(2):127–35.CrossRefPubMed
36.
go back to reference John B, Tan BK, Dainty S, Spanel P, Smith D, Davies SJ. Plasma volume, albumin, and fluid status in peritoneal dialysis patients. Clin J Am Soc Nephrol. 2010;5(8):1463–70.CrossRefPubMedPubMedCentral John B, Tan BK, Dainty S, Spanel P, Smith D, Davies SJ. Plasma volume, albumin, and fluid status in peritoneal dialysis patients. Clin J Am Soc Nephrol. 2010;5(8):1463–70.CrossRefPubMedPubMedCentral
37.
go back to reference Ate¸S K, Nergizo˘glu G, Keven K, Sen A, Kutlay S, Ertürk S, et al. Effect of fluid and sodium removal on mortality in peritoneal dialysis patients. Kidney Int. 2001;60:767–76.CrossRef Ate¸S K, Nergizo˘glu G, Keven K, Sen A, Kutlay S, Ertürk S, et al. Effect of fluid and sodium removal on mortality in peritoneal dialysis patients. Kidney Int. 2001;60:767–76.CrossRef
38.
go back to reference Davies SJ, Phillips L, Russell GI. Peritoneal solute transport predicts survival on CAPD independently of residual renal function. Nephrol Dial Transplant. 1998;13:962–8.CrossRefPubMed Davies SJ, Phillips L, Russell GI. Peritoneal solute transport predicts survival on CAPD independently of residual renal function. Nephrol Dial Transplant. 1998;13:962–8.CrossRefPubMed
39.
go back to reference Molnar MZ, Mehrotra R, Duong U, Kovesdy CP, Kalantar-Zadeh K. Association of hemoglobin and survival in peritoneal dialysis patients. Clin J Am Soc Nephrol. 2011;6(8):1973–81.CrossRefPubMedPubMedCentral Molnar MZ, Mehrotra R, Duong U, Kovesdy CP, Kalantar-Zadeh K. Association of hemoglobin and survival in peritoneal dialysis patients. Clin J Am Soc Nephrol. 2011;6(8):1973–81.CrossRefPubMedPubMedCentral
40.
go back to reference Udayaraj UP, Steenkamp R, Caskey FJ, Rogers C, Nitsch D, Ansell D, et al. Blood pressure and mortality risk on peritoneal dialysis. Am J Kidney Dis. 2009;53:70–8.CrossRefPubMed Udayaraj UP, Steenkamp R, Caskey FJ, Rogers C, Nitsch D, Ansell D, et al. Blood pressure and mortality risk on peritoneal dialysis. Am J Kidney Dis. 2009;53:70–8.CrossRefPubMed
Metadata
Title
How has peritoneal dialysis changed over the last 30 years: experience of the Verona dialysis center
Authors
Gianluigi Zaza
Carlo Rugiu
Alessandra Trubian
Simona Granata
Albino Poli
Antonio Lupo
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2015
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-015-0051-3

Other articles of this Issue 1/2015

BMC Nephrology 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.